Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update

May 15, 2024

https://www.globenewswire.com/news-release/2024/05/15/2882982/0/en/Molecular-Templates-Inc-Reports-First-Quarter-2024-Financial-Results-and-Corporate-Update.html

AUSTIN, Texas, May 15, 2024 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq:MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (“ETBs”), to create novel therapies with potent differentiated mechanisms of action, today reported financial results and business updates for the first quarter of 2024.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.